Dhani NC, Hirte HW, Wang L, Burnier JV, et al. Phase II Trial of Cabozantinib in Recurrent/Metastatic Endometrial Cancer: A Study of the Princess Margaret, Chicago and California Consortia (NCI9322/PHL86). Clin Cancer Res 2020 Jan 28. pii: 1078-0432.CCR-19-2576.
PMID: 31992589